Search results
Is this FTSE 100 behemoth about to make investors rich all over again?
Fool.co.uk via Yahoo Finance UK· 7 days agoThis FTSE 100 stock recently unveiled plans to almost double revenue to $80bn by 2030. Our writer...
AstraZeneca's (AZN) Truqap Misses Endpoints in TNBC Study
Zacks via Yahoo Finance UK· 4 days agoAstraZeneca's (AZN) phase III CAPItello-290 study evaluating Truqap plus chemotherapy in patients...
AstraZeneca lung cancer drug approved in the US
This Is Money· 6 days agoAstraZeneca revealed that US Food and Drug Administration has approved its lung cancer drug alongside other chemotherapy treatment. In a statement,...
One AstraZeneca Insider Raised Stake By 50% In Previous Year
Simply Wall St. via Yahoo Finance UK· 5 days agoViewing insider transactions for AstraZeneca PLC's (LON:AZN ) over the last year, we see that...
AstraZeneca trial fails to treat 'challenging' breast cancer
ShareCast· 5 days agoAstraZeneca announced on Tuesday that the phase three ‘CAPItello-290’ trial for ‘Truqap’, or...
Astrazeneca drug gets US approval for use on endometrial cancer
CityAM via Yahoo Finance UK· 6 days agoA company logo is seen at the AstraZeneca HQ Astrazeneca’s Imfinzi drug has been approved in the US...
AstraZeneca's Imfinzi gets US approval for endometrial cancer patients
ShareCast· 6 days agoAstraZeneca said its Imfinzi cancer treatment had been approved in the US as treatment for adult patients with primary advanced or recurrent endometrial cancer.
Astrazeneca (AZN) Stock Sinks As Market Gains: Here's Why
Zacks via Yahoo Finance UK· 5 days agoAstrazeneca (AZN) closed at $79.31 in the latest trading session, marking a -0.35% move from the...
AstraZeneca's (AZN) Imfinzi Gets FDA Nod in Expanded Use
Zacks via Yahoo Finance UK· 5 days agoThe FDA approves AstraZeneca's (AZN) Imfinzi in combination with chemotherapy for treating mismatch...
AstraZeneca's breast cancer drug combination fails in late-stage trial
Reuters· 5 days ago, opens new tab said on Tuesday its breast cancer drug, Truqap, in combination with chemotherapy...